Showing results (81-90 of 229) with videos related to
Sort By:
Pageof 23
Journal of Diabetes and Its Complications|October 1, 1995
Extracellular matrix and its interactions in the diabetic kidney: a molecular biological approachR E Gilbert, A Cox, M Dziadek, et al.Current Drug Targets|July 20, 2005
The role of AGEs and AGE inhibitors in diabetic cardiovascular diseaseM C Thomas, J W Baynes, S R Thorpe, et al.Atherosclerosis|April 17, 1998
Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbitS Panagiotopoulos, R C O'Brien, R Bucala, et al.Hypertension (Dallas, Tex. : 1979)|September 1, 1995
Amylin stimulates plasma renin concentration in humansM E Cooper, P G McNally, P A Phillips, et al.Journal of Hypertension|December 18, 1998
Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathyJ R Rumble, R E Gilbert, A Cox, et al.Diabetes|January 1, 1997
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetesT J Allen, M J Waldron, D Casley, et al.Diabetologia|February 8, 2006
Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammationA C Calkin, M E Cooper, K A Jandeleit-Dahm, et al.The Journal of Diabetic Complications|April 1, 1989
Intermittent diabetic microalbuminuria: association with blood pressure, glycemic control, and protein intakeM E Cooper, R C O'Brien, R M Murray, et al.Journal of Diabetes and Its Complications|April 1, 1993
Prediction of persistent microalbuminuria in patients with diabetes mellitusL A Bach, R E Gilbert, M E Cooper, et al.Diabetes Research and Clinical Practice|January 7, 1988
Comparison of early renal dysfunction in type I and type II diabetes: differing associations with blood pressure and glycaemic controlG Jerums, M E Cooper, E Seeman, et al.Pageof 23